Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Resident mesenchymal progenitor cells require autocrine IGF-I in homeostatic and regenerating skeletal muscle.

Stem cell reports·2026
Same author

Reduced skeletal muscle perfusion accompanies skeletal muscle atrophy after severe spinal cord injury.

Journal of applied physiology (Bethesda, Md. : 1985)·2026
Same author

Fibro-adipogenic progenitor cells from murine SMA muscles are intrinsically adipogenic.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Functional and structural pathologies in skeletal muscle of a rat model of Duchenne muscular dystrophy.

Skeletal muscle·2026
Same author

Automated Classification of Store-Operated Calcium Entry Activity and Disease Conditions in Murine Skeletal Muscle Images Using Machine Learning.

Muscle & nerve·2026
Same author

Intermittent AP-1 activation in muscles contributes to exercise-induced health benefits.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: May 12, 2026

Mouse In Vivo Placental Targeted CRISPR Manipulation
07:39

Mouse In Vivo Placental Targeted CRISPR Manipulation

Published on: April 14, 2023

New Modulators for IGF-I Activity within IGF-I Processing Products.

Becky K Brisson1, Elisabeth R Barton

  • 1Department of Anatomy and Cell Biology, School of Dental Medicine, Pennsylvania Muscle Institute, University of Pennsylvania Philadelphia, PA, USA.

Frontiers in Endocrinology
|April 2, 2013
PubMed
Summary
This summary is machine-generated.

Insulin-like growth factor I (IGF-I) and its E-peptides may work together to regulate muscle growth. This review proposes a new model where E-peptides modulate IGF-I receptor activity, rather than acting independently.

Keywords:
E-peptidesIGF-Iglycosylationhypertrophysignalingskeletal muscle

More Related Videos

Separation of Rat Epidermis and Dermis with Thermolysin to Detect Site-Specific Inflammatory mRNA and Protein
08:45

Separation of Rat Epidermis and Dermis with Thermolysin to Detect Site-Specific Inflammatory mRNA and Protein

Published on: September 29, 2021

Related Experiment Videos

Last Updated: May 12, 2026

Mouse In Vivo Placental Targeted CRISPR Manipulation
07:39

Mouse In Vivo Placental Targeted CRISPR Manipulation

Published on: April 14, 2023

Separation of Rat Epidermis and Dermis with Thermolysin to Detect Site-Specific Inflammatory mRNA and Protein
08:45

Separation of Rat Epidermis and Dermis with Thermolysin to Detect Site-Specific Inflammatory mRNA and Protein

Published on: September 29, 2021

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Endocrinology

Background:

  • Insulin-like growth factor I (IGF-I) is crucial for muscle development.
  • IGF-I is processed from a precursor that includes E-peptides.
  • The precise function of E-peptides and their interaction with IGF-I remains unclear.

Purpose of the Study:

  • To review the literature on IGF-I processing and E-peptide actions in skeletal muscle.
  • To propose a novel model of IGF-I and E-peptide synergy.
  • To suggest future research directions for understanding E-peptide function.

Main Methods:

  • Literature review and synthesis of existing research.
  • Analysis of previous studies attempting to differentiate IGF-I and E-peptide effects.
  • Formulation of a new mechanistic model for IGF-I/E-peptide interaction.

Main Results:

  • Evidence suggests E-peptides influence cell growth and muscle hypertrophy.
  • Previous research has yielded controversial results regarding E-peptide activity.
  • A new model posits E-peptides coordinate with IGF-I to modulate IGF-I receptor activity.

Conclusions:

  • E-peptides may not have independent receptors but rather synergize with IGF-I.
  • The interaction between E-peptides and IGF-I is critical for modulating IGF-I receptor signaling.
  • Further experiments are needed to validate the proposed model of IGF-I/E-peptide synergy.